TCL Archive NCI To Boost Investigator-Initiated Grants Using 5.7% Increase, Cuts In Contracts February 9, 1996
TCL Archive Early-Stage HER2+ Breast Cancer Patients Are At Significant Risk Of Recurrence December 26, 2008
TCL Archive Phase III Trial of Imbruvica Halted, Following Increases in Progression-Free Survival January 31, 2014